JDVSX
Price
$16.63
Change
+$0.06 (+0.36%)
Updated
Aug 6 closing price
Net Assets
470.63M
RLBCX
Price
$36.81
Change
+$0.10 (+0.27%)
Updated
Aug 6 closing price
Net Assets
252.49B
Interact to see
Advertisement

JDVSX vs RLBCX

Header iconJDVSX vs RLBCX Comparison
Open Charts JDVSX vs RLBCXBanner chart's image
JPMorgan Diversified I
Price$16.63
Change+$0.06 (+0.36%)
VolumeN/A
Net Assets470.63M
American Funds American Balanced R3
Price$36.81
Change+$0.10 (+0.27%)
VolumeN/A
Net Assets252.49B
JDVSX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JDVSX vs. RLBCX commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDVSX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 252B vs. JDVSX (471M). JDVSX pays higher dividends than RLBCX: JDVSX (2.56) vs RLBCX (1.56). JDVSX was incepted earlier than RLBCX: JDVSX (24 years) vs RLBCX (23 years). JDVSX (0.97) is less costly to investors than RLBCX (0.89). JDVSX is a more actively managed with annual turnover of: 63.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than JDVSX: RLBCX (250) vs JDVSX (1000000). JDVSX annual gain was more profitable for investors over the last year : 11.54 vs. RLBCX (10.44). RLBCX return over 5 years is better than : 34.86 vs. JDVSX (7.42).
JDVSXRLBCXJDVSX / RLBCX
Total Expense Ratio0.710.8980%
Annual Report Gross Expense Ratio0.970.89109%
Fund Existence24 years23 years-
Gain YTD7.6338.41891%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets471M252B0%
Annual Yield % from dividends2.561.56165%
Returns for 1 year11.5410.44110%
Returns for 3 years22.3730.1774%
Returns for 5 years7.4234.8621%
Returns for 10 years17.0661.8428%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRN148.3220.09
+15.67%
Stride
CFG46.93-0.37
-0.78%
Citizens Financial Group
CMPS4.36-0.12
-2.68%
COMPASS Pathways Plc
CNTB2.13-0.07
-3.18%
Connect Biopharma Holdings Limited
APRE1.64-0.15
-8.38%
Aprea Therapeutics